These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6696520)

  • 21. Sodium aurothiomalate toxicity and sulphoxidation capacity in rheumatoid arthritic patients.
    Ayesh R; Mitchell SC; Waring RH; Withrington RH; Seifert MH; Smith RL
    Br J Rheumatol; 1987 Jun; 26(3):197-201. PubMed ID: 3107649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action of sodium aurothiomalate on erythrocyte membrane.
    Campbell JM; Reglinski J; Smith WE; Porter D; Sturrock RD
    Ann Rheum Dis; 1992 Aug; 51(8):969-71. PubMed ID: 1417122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue disposition and excretion of gold and 14C in rats treated with sodium aurothio[1,4-14C]malate or thio [1,4-14C] malic acid.
    Taylor A; King LJ; Marks V
    Xenobiotica; 1985 Mar; 15(3):221-6. PubMed ID: 3927598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.
    Jessop JD; Johns RG
    Ann Rheum Dis; 1973 May; 32(3):228-32. PubMed ID: 4268483
    [No Abstract]   [Full Text] [Related]  

  • 27. No significant effects of sodium aurothiomalate on haem metabolism and mixed function oxygenase activity in patients with rheumatoid arthritis.
    Herrick AL; Hodgkiss R; Reed P; Weinkove C; Jayson MI; Houston B
    Clin Exp Rheumatol; 1999; 17(4):461-2. PubMed ID: 10464558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.
    Gerber RC; Paulus HE; Jennrich RI; Lederer M; Bluestone R; Blahd WH; Pearson CM
    J Lab Clin Med; 1974 May; 83(5):778-89. PubMed ID: 4207022
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of gold levels and distribution in guinea pig serum.
    Kamel H; Brown DH; Ottaway JM; Smith WE; Cottney J; Lewis AJ
    Arthritis Rheum; 1978 May; 21(4):441-6. PubMed ID: 418787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.
    van Roon EN; van de Laar MA; Janssen M; Kruijsen MW; Jansen TL; Brouwers JR
    J Rheumatol; 2005 Jun; 32(6):1026-30. PubMed ID: 15940762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kidney tubular injury in the use of sodium aurothiomalate and its detection by determination of urinary beta-2-microglobulin].
    Ulreich A; Rainer F; Sedlmayr DP; Leb G; Pfeiffer K
    Wien Klin Wochenschr Suppl; 1984; 156():56-7. PubMed ID: 6442061
    [No Abstract]   [Full Text] [Related]  

  • 33. [Reactions against sodium-auro-thiomalate in the treatment of rheumatoid arthritis].
    Cruz Filho A; Gomes IJ; Budaruiche JS
    Z Rheumatol; 1979; 38(9-10):381-4. PubMed ID: 118603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gold therapy in rheumatoid arthritis.
    Majoos FL; Klemp P; Meyers OL; Briggs B
    S Afr Med J; 1981 Jun; 59(27):971-4. PubMed ID: 6787722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
    Wiland P; Głowska A; Chlebicki A; Szechiński J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.
    Griffin AJ; Gibson T; Huston G; Taylor A
    Ann Rheum Dis; 1981 Jun; 40(3):250-3. PubMed ID: 6787995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate.
    Walters MT; Cawley MI
    Ann Rheum Dis; 1988 Nov; 47(11):924-9. PubMed ID: 3144941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta 2-Microglobulin levels in serum and urine of rheumatoid arthritis patients on gold therapy.
    Latt D; Weiss JB; Jayson MI
    Ann Rheum Dis; 1981 Apr; 40(2):157-60. PubMed ID: 6164344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Another anaphylactic reaction after gold (aurothiomalate) injection.
    Neustadt DH
    J Rheumatol; 1995 Jan; 22(1):190. PubMed ID: 7699674
    [No Abstract]   [Full Text] [Related]  

  • 40. Gold excretion and retention during auranofin treatment: a preliminary report.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():61-7. PubMed ID: 385875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.